Improving care delivery for patients with rare cancers: A phase II trial of durvalumab in combination with tremilumimab in subjects with advanced rare tumors in a large community health care system.
2018 ◽
Vol 36
(15_suppl)
◽
pp. e18535-e18535
Keyword(s):
Phase Ii
◽
2015 ◽
Vol 21
(3)
◽
pp. 288-295
◽
2012 ◽
Vol 40
(8)
◽
pp. 771-773
◽
2019 ◽
Vol 229
(4)
◽
pp. e7
1978 ◽
Vol 26
(3)
◽
pp. 130-135
◽
Keyword(s):
2012 ◽
Vol 60
(6)
◽
pp. 728-729
Keyword(s):
2020 ◽
Vol 17
(2)
◽
pp. 111-118